恒指反覆倒跌 惟创科(00669.HK)续涨逾3%高见68.95元再破顶
中美15日正式签署首阶段贸易协议,加上本月费城联储制造业指数急弹至17,创五个月高,更远胜市场预期仅回升至3.8,反映大西洋沿岸中部地区制造业活动增长再度急速加快。业务主要集中於北美洲的创科实业(00669.HK)跑赢,股价三连涨兼今天再创上市新高,最多涨4.5%,高见68.95元(三天最多累升8.2%),现造68.1元,续升逾3%,为最强蓝筹,成交已达185万股,涉资1.266亿元。
美国经济数据理想及企业绩佳,带动美股昨晚全面高收续升0.8%-1.1%屡创纪录高。不过,港股连续第二天表现反覆,恒指继昨天反覆弹不足0.4%後,今早高开105点报28,988,早段曾反覆倒跌69点低见28,813获承接,再度回升,最多升218点,高见29,101再次遇压,现造28,876,倒跌6点,成交额已达435亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.